A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.
申请公布号
WO2007145863(A2)
申请公布日期
2007.12.21
申请号
WO2007US13030
申请日期
2007.05.31
申请人
OREXIGEN THERAPEUTICS, INC.;MCKINNEY, ANTHONY A.;TOLLEFSON, GARY D.;SOLTERO, RICHARD;DUNZO, THEA ELISE
发明人
MCKINNEY, ANTHONY A.;TOLLEFSON, GARY D.;SOLTERO, RICHARD;DUNZO, THEA ELISE